Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • jevcampe
    Member
    • Apr 2013
    • 13

    #1

    Steps prior and during de novo assembly (clcbio)

    Dear all,

    I have some questions considering steps prior a de novo assembly. I have normalized cDNA Miseq (pair end) data from two marine nematode species (no reference genome available of any marine nematodes) which I want to assembly to create a transcriptome. The sequencing company has done some things for me already:

    1. Quality trimming: We trim low quality ends (< Q20) with FastX 0.0.13 [1].
    2. Adapter trimming: The adapters are trimmed only at the end (at least 10bp
    overlap and 90% match) with cutadapt 1.2.1 [3].
    3. Quality fltering: Using FastX 0.0.13 and ShortRead 1.16.3, we remove in
    succession small reads (length < 50 bp), polyA-reads (more than 90% of the
    bases equal A), ambiguous reads (containing N), low quality reads (more than
    50% of the bases < Q25) and artifact reads (all but 3 bases in the read equal one
    base type).
    4. Making pairing consistent: Filtering reads may remove one read of a pair and
    make paired fastq-?les inconsistent. In this step we remove reads that belong
    to broken pairs and save them in separate fastq
    5. Removal of contaminants: Using bowtie 2.0.0-beta5, we identify reads that
    align to phixillumina and remove them.

    So here it ends and I step in. I have uploaded my sequences in CLCbio and trimmed the sequences for the cDNA adapters, which were required to amplify my normalized cDNA libraries to increase the amount of cDNA.

    My questions are:
    - Prior to a de novo assembly there is the option to merge pair end reads giving two data sets: one with merged sequences and one without. Is it a good option to merge paired end reads or should the de novo assembly start from the original fastq files? Or should we do both, merging the pair end data and using these merged sequences together with the original data for my de novo assembly?

    - During de novo assembly there is the option of scaffolding. I'm not sure whether this option is good. It indeed will create longer contigs but does it give downstream problems during annotation. I mean: If two genes are in very close proximity (or even on oposite strands) there is a possibility that they will end up in 1 contig. When blasting this contig won't you miss 1 of the 2 genes?

    - How is it possible that when mapping reads back to the transcriptome 10% was not mapped?


    Thanks in advance
  • rafaelbsvaladares
    Junior Member
    • Nov 2012
    • 1

    #2
    Hi, I have exactly the same question, did you find the answer ?

    Comment

    • guptavipin142
      Member
      • Mar 2014
      • 12

      #3
      hi Jevcampe and rafaelbsvaladares

      Can you suggest me the library construction (e.g. 2K, 500pb) used for your illumina cDNA sequencing.

      As I am newly working on Metatranscriptomics, I have done RNA isolation and enrichment and its cDNA conversion. Now I want to sequence it with illumina Hiseq and for that I need to tell company the library I want to use for sequencing.

      Thanks in advance

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
        by SEQadmin2



        Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

        Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
        ...
        10-14-2026, 09:55 AM
      • SEQadmin2
        New Genomics Technologies Take Aim at Long-Standing Limits
        by SEQadmin2


        Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

        We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
        ...
        09-28-2026, 10:25 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 10-22-2026, 11:13 AM
      0 responses
      27 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-22-2026, 10:48 AM
      0 responses
      20 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-15-2026, 10:52 AM
      0 responses
      36 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-14-2026, 05:39 AM
      0 responses
      43 views
      0 reactions
      Last Post SEQadmin2  
      Working...